Chad R. Baker’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-166,015
Closed -$7.51M 57
2019
Q4
$7.51M Hold
166,015
2.49% 15
2019
Q3
$6.75M Hold
166,015
2.4% 16
2019
Q2
$7.14M Hold
166,015
2.49% 14
2019
Q1
$6.37M Hold
166,015
2.31% 17
2018
Q4
$5.87M Hold
166,015
2.53% 15
2018
Q3
$6.39M Hold
166,015
2.33% 15
2018
Q2
$5.43M Hold
166,015
2.17% 19
2018
Q1
$4.54M Hold
166,015
1.79% 22
2017
Q4
$4.12M Hold
166,015
1.63% 27
2017
Q3
$4.84M Sell
166,015
-2,210
-1% -$61K 1.9% 20
2017
Q2
$4.66M Hold
168,225
1.85% 23
2017
Q1
$4.18M Hold
168,225
1.7% 25
2016
Q4
$3.64M Hold
168,225
1.61% 26
2016
Q3
$4M Hold
168,225
1.72% 24
2016
Q2
$3.93M Hold
168,225
1.75% 24
2016
Q1
$3.16M Hold
168,225
1.44% 32
2015
Q4
$3.1M Buy
+168,225
New +$3.01M 1.39% 31

Other funds holding BSX

Chad R. Baker's BSX Position: Q1 2020 in Review

Chad R. Baker sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 166,015 shares — an estimated $7.51M sold.

Chad R. Baker first reported a position in BSX in Q4 2015 and held it in 17 quarters. The position peaked at $7.51M in Q4 2019. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Chad R. Baker reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Chad R. Baker sold 166,015 Boston Scientific shares in Q1 2020, an estimated $7.51M.
  • Chad R. Baker first reported a position in Boston Scientific in Q4 2015 and held it in 17 quarters.
  • Chad R. Baker's Boston Scientific position peaked at $7.51M in Q4 2019.
  • 801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Chad R. Baker's 13F filing for Q1 2020, filed 1 May 2020.